News & Perspective

Nov 30, 2015

Nov 30, 2015

Flu Scan for Nov 30, 2015

Avian flu in Vietnam, Canada
US flu uptick

Sep 11, 2017

Sep 11, 2017
Nasal spray flu vaccine

Performance of inhaled flu vaccine confounds experts

Experts ponder why FluMist performed poorly in the US but well elsewhere.

Feb 05, 2015

Feb 05, 2015
Photo of puzzle pieces

UK, Canada add to bad news on this year's flu vaccine

Researchers in both places found vaccine effectiveness to be well below the already-low US numbers.

Feb 14, 2013

Feb 14, 2013

Euro studies show flu vaccine working best against type B

(CIDRAP News) – New European studies reported today in Eurosurveillance suggest that this year's influenza vaccine is providing good protection against influenza B viruses but only moderate protection against type A—findings more or less consistent with earlier results in the United States.

Jan 31, 2013

Jan 31, 2013

Studies: Flu vaccine effectiveness waned over 2011-12 season

(CIDRAP News) – It's been more or less an article of faith that influenza vaccination in the fall will protect a person through the winter flu season, but three studies published today in Eurosurveillance are challenging that view.

Feb 11, 2011

Feb 11, 2011

Study showing high effectiveness for H1N1 vaccine stirs debate

(CIDRAP News) – A recent case-control study estimates that the adjuvanted pandemic H1N1 influenza vaccine used in Canada was effective 93% of the time, a substantially higher figure than seen in several other studies and one that has raised some eyebrows among other flu vaccine researchers.

Feb 13, 2009

Feb 13, 2009

WHO picks new B strain for 2009-10 flu vaccine

(CIDRAP News) – Because of a suboptimal match between this year's flu vaccine and circulating influenza B viruses, the World Health Organization (WHO) has recommended changing one of the three strains used in flu vaccines for the Northern Hemisphere next fall and winter.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Aug 16, 2007

Aug 16, 2007

Glaxo sells more H5N1 vaccine to US, launches trial

(CIDRAP News) – The British pharmaceutical company GlaxoSmithKline (GSK) recently announced another major order of prepandemic H5N1 influenza vaccine from the US Department of Health and Human Services (HHS), along with plans to launch a North American clinical trial of the vaccine.

Sep 19, 2006

Sep 19, 2006

Sanofi tests H7N1 flu vaccine for pandemic readiness

(CIDRAP News) – Sanofi Pasteur today announced the start of the first clinical trial of an H7N1 influenza vaccine, intended to guard against the threat of a pandemic caused by H7 strains of avian influenza.

Current concern about a flu pandemic focuses mainly on the H5N1 avian flu virus, which has infected at least 247 people and killed 144. But H7 avian flu viruses have caused a number of mild illness cases and one death in the past 3 years.

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»